Kilitch Drugs (India) Limited has informed the Exchange regarding a press release dated November 14, 2025, titled "Press Release - H1FY26 Financial Results".
KILITCH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kilitch Drugs (India) Limited has submitted a press release to NSE dated November 14, 2025, covering its financial results for the first half of FY26 (April to September 2025). The headline only confirms the filing of the press release; no specific revenue, profit, or margin figures are provided in the announcement text. Investors would need to refer to the actual press release or the company's detailed half-yearly results for the underlying numbers. This is a standard regulatory disclosure informing the exchange and public that the H1FY26 results communication has been issued.
This is a routine filing notification and is unlikely to move the stock on its own. Shareholders should review the actual H1FY26 numbers in the press release to assess business performance and any year-on-year changes.